outcome of board meeting
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
CHD Chemicals' board approved unaudited financial results for Q3 FY26 and the nine months ended December 31, 2025 on February 14, 2026. Revenue from operations fell sharply to Rs 132.12 lakhs in Q3 FY26, down about 61% from Rs 339.08 lakhs in Q3 FY25. For the nine-month period, revenue dropped to Rs 372.06 lakhs from Rs 545.04 lakhs, a decline of roughly 32% year-on-year. The company posted a loss after tax of Rs 4.78 lakhs in Q3 FY26 and Rs 25.94 lakhs for 9M FY26, wider than the Rs 19.64 lakh loss in 9M FY25. Basic EPS for 9M FY26 was negative Rs 1.99, sharply worse than negative Rs 0.26 in the year-ago period. Statutory auditors GAMS & Associates LLP carried out a limited review with no qualifications noted in the available text.
Sharp revenue contraction combined with widening losses is a negative signal for shareholders, pointing to weakening demand or loss of business. Continued losses and declining topline raise concerns about the company's path to profitability and warrant close monitoring of upcoming quarters.